Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-31

FDA Approved: LINAGLIPTIN — Original Application (Sunshine Lake Pharma Co., Ltd.)

View source ↗

Summary

FDA approved the original application for linagliptin by Sunshine Lake Pharma Co., Ltd., delivering a generic version of the DPP-4 inhibitor for adults with typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linagliptin (linagliptin)

Snippet

ORIG AP for LINAGLIPTIN (LINAGLIPTIN)